Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

To main content To sitemap To news Check availability details

Biomarkers for HuMax-IL8 cancer treatment patient selection

Reference number
Coordinator Cormorant Pharmaceuticals AB
Funding from Vinnova SEK 23 950
Project duration May 2014 - October 2014
Status Completed

Last updated 25 November 2019

Reference number 2014-03155

Page statistics